Literature DB >> 24392368

Increased levels of markers of oxidative stress and inflammation in patients with rheumatic mitral stenosis predispose to left atrial thrombus formation.

Vinay Kumar Pulimamidi1, Vengatesan Murugesan1, Medha Rajappa2, Santhosh Satheesh3, Kottenyen Thazhath Harichandrakumar4.   

Abstract

BACKGROUND: Rheumatic mitral stenosis (MS) causes stagnation of blood flow, leading to thrombus formation in the left atrium (LA), which may lead to systemic thromboembolic complications. We compared alterations in circulating levels of pro-/anti-oxidants and markers of inflammation in patients of severe rheumatic MS with and without LA thrombus and studied their predictive power to detect the presence of LA thrombus in patients with rheumatic MS.
MATERIAL AND METHODS: This is a cross-sectional study of 80 patients with rheumatic MS, evaluated for percutaneous mitral commisurotomy. Group 1 comprised of patients with rheumatic MS with LA thrombus (n=35) and Group 2 included patients with rheumatic MS without LA thrombus (n=45). The following oxidative stress markers-malondialdehyde (MDA), protein carbonyls, total oxidant status and total antioxidant status and inflammation markers-high sensitivity C-reactive protein (hs-CRP), total sialic acid (TSA) and protein-bound sialic acid (PBSA) were estimated in all study subjects.
RESULTS: Levels of plasma MDA, protein carbonyl and total oxidant status were significantly elevated, whilst the total antioxidant status levels were significantly lowered, in Group 1, as compared with Group 2. hs-CRP, TSA and PBSA levels showed a significant rise in Group 1 patients, as compared with Group 2.
CONCLUSION: Our results suggest that circulating levels of MDA, protein carbonyl and PBSA were independent predictors of occurrence of LA thrombus in patients with rheumatic MS.

Entities:  

Keywords:  Inflammation; Left Atrium; Oxidative stress; Rheumatic mitral stenosis; Thrombosis

Year:  2013        PMID: 24392368      PMCID: PMC3879848          DOI: 10.7860/JCDR/2013/7251.3570

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  18 in total

Review 1.  Rheumatic fever.

Authors:  G H Stollerman
Journal:  Lancet       Date:  1997-03-29       Impact factor: 79.321

2.  Mitral valve disease, systemic embolism and anticoagulants.

Authors:  H A Fleming; S M Bailey
Journal:  Postgrad Med J       Date:  1971-09       Impact factor: 2.401

3.  A new automated colorimetric method for measuring total oxidant status.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2005-10-07       Impact factor: 3.281

4.  Lipid peroxidation associated protein damage in rat brain crude synaptosomal fraction mediated by iron and ascorbate.

Authors:  H Chakraborty; S N Ray; S Chakrabarti
Journal:  Neurochem Int       Date:  2001-10       Impact factor: 3.921

5.  A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.

Authors:  Young M Kim; Tomasz J Guzik; Yin Hua Zhang; Mei Hua Zhang; Hassan Kattach; Chandi Ratnatunga; Ravi Pillai; Keith M Channon; Barbara Casadei
Journal:  Circ Res       Date:  2005-08-25       Impact factor: 17.367

6.  Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases.

Authors:  Samuel C Dudley; Nyssa E Hoch; Louise A McCann; Clegg Honeycutt; Laura Diamandopoulos; Tohru Fukai; David G Harrison; Sergey I Dikalov; Jonathan Langberg
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

7.  Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP).

Authors:  Y Y Chiu-Braga; S Y Hayashi; M Schafranski; I J T Messias-Reason
Journal:  Int J Cardiol       Date:  2005-06-08       Impact factor: 4.164

8.  Discrimination ratio analysis of inflammatory markers: implications for the study of inflammation in chronic disease.

Authors:  L M Browning; J D Krebs; S A Jebb
Journal:  Metabolism       Date:  2004-07       Impact factor: 8.694

9.  C-reactive protein decreases prostacyclin release from human aortic endothelial cells.

Authors:  Senthil Kumar Venugopal; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

Review 10.  Rheumatic heart disease: progress and challenges in India.

Authors:  Bela Shah; Meenakshi Sharma; Rajesh Kumar; K N Brahmadathan; Vinod Joseph Abraham; Rajan Tandon
Journal:  Indian J Pediatr       Date:  2012-09-02       Impact factor: 1.967

View more
  1 in total

1.  The association of plasma high-sensitivity C-reactive protein level with rheumatic heart disease: The possible role of inflammation.

Authors:  Armin Attar; Parvin Marzban; Alireza Moaref; Kamran Aghasadeghi
Journal:  Indian Heart J       Date:  2017-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.